Heidelberg Druck's Sodium-Ion Bet Puts a Century-Old Print Giant on Unfamiliar Ground

Heidelberger Druckmaschinen bets on sodium-ion storage with PHENOGY, lifting shares 7% weekly, but margin concerns loom before quarterly results.

For a company whose name has been synonymous with printing presses for over 170 years, the pivot could hardly be more stark. Heidelberger Druckmaschinen is now positioning itself as a manufacturer of sodium-ion battery storage systems, a move that has handed the struggling stock its best week in recent memory — and set up a pivotal test when the company reports quarterly figures next month.

The catalyst arrived on July 21, when the group's wholly owned subsidiary HD Advanced Technologies (HDAT) unveiled a cooperation agreement with PHENOGY AG. Under the terms of the deal, HDAT will take on the complete industrial production of PHENOGY's energy storage systems — spanning procurement, manufacturing, rollout, installation, service and maintenance — under a long-term framework supply contract. Production of cabinets, containers and system products will initially be geared toward the European market from German facilities, with a potential expansion into the US for North American customers. The two companies are also laying the groundwork for a joint venture to develop and produce sodium-ion battery cells, combining PHENOGY's cell chemistry with Heidelberg's proprietary printing technology — an unusual marriage of precision engineering and next-generation energy storage that the group hopes will offer a viable alternative to lithium-ion chemistry.

The timing of the announcement was no accident. Just two days later, on July 23, shareholders voted to waive the dividend for the 2025/2026 financial year entirely, freeing up capital for the company's transformation into what management calls a "technology integrator" — with battery storage and drone defense as the two new growth pillars. The PHENOGY deal represents the first visible proof that this strategy can generate actual orders rather than just presentations.

A Rally Built on Hope — and a Long Way From Home

The market has responded enthusiastically. The stock closed Friday at EUR 1.46, up 1.89 percent on the day and 7.13 percent higher over the course of the week. That momentum follows a 4.5 percent recovery since the company announced it would take over production of POLAR machines, whose existing plant in Hofheim is being sold out from under them.

Yet the technical picture tells a more cautious story. The shares still sit 9.79 percent below their 200-day moving average of EUR 1.62, and remain roughly 13 percent above the 52-week low of EUR 1.29 touched back in March. The relative strength index sits at 65, suggesting buying pressure but also approaching overbought territory. For all the recent gains, the stock is still down 28.18 percent since the start of the year.

The Margin Question Looms Over the Narrative

The central debate among investors comes down to a single metric: the operating margin. In the just-completed 2025/2026 fiscal year, net profit improved to EUR 15 million from EUR 5 million a year earlier, on revenue of EUR 2.293 billion. But the adjusted EBITDA margin slipped to 6.6 percent — and that came after an April profit warning in which the company blamed launch costs in the defense sector and customer investment hesitancy tied to the Iran conflict.

The question now is whether the new growth areas — drone defense, battery storage, and the recently acquired businesses in the core print operation — can generate enough revenue to offset their own startup costs before they drag margins down further. The POLAR production takeover was announced in July, while the integration of manroland sheetfed's lifecycle business and global sales and service operations was completed in June, a deal expected to add around EUR 100 million in annual sales and encompassing roughly 35 country organizations with about 600 employees.

Management continuity is assured through the transition: the supervisory board extended CEO Jürgen Otto's contract through July 2029 — limited by the company's age cap — and CFO David Schmedding's through June 2031, with both extensions taking effect at the start of July.

August 19 Becomes the Reckoning

The next hard evidence arrives on August 19, when Heidelberg reports results for the first quarter of fiscal 2026/2027. A robust outlook could extend the rally and validate the diversification thesis. But if margins deteriorate further, or the integration of POLAR, manroland sheetfed and HDAT proves costlier than planned, last week's enthusiasm could evaporate quickly — and the stock would likely slide back toward its 200-day average or below.

The dividend waiver adds another layer of scrutiny: the company itself is signaling it sees no basis for shareholder payouts yet, a fourth consecutive year without distribution. For a stock that has spent most of the past year in decline, the sodium-ion partnership offers a fresh narrative. Whether it becomes a genuine second pillar alongside the print business — or merely a brief respite in a longer downturn — will depend on whether the August numbers can turn headlines into hard revenue.